HDL2 and CSF carotenoids and tocopherols

Biomarker

1 paper1 finding

  • Human trial1

Interventions

1

Obicetrapib

upin humans1

1 study
  1. Obicetrapib increases HDL2 and CSF carotenoids and tocopherols in humans.

    “demonstrated that HDL2 and CSF carotenoid and tocopherol levels were increased by obicetrapib.”

    Human trialearly Alzheimer's diseaseplasma and cerebrospinal fluid10 mg/dn = 13

    Cholesteryl ester transfer protein (CETP) inhibition and high-density lipoprotein particle composition: consequences for atherogenesis and neurodegeneration

    Scientific reports16 Oct 2026

More on Obicetrapib

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months